Comment
doi: 10.1016/S0140-6736(20)30052-0.
Challenging the management of drug-resistant tuberculosis
Affiliations
- PMID: 32145789
- DOI: 10.1016/S0140-6736(20)30052-0
Item in Clipboard
Comment
Challenging the management of drug-resistant tuberculosis
Lancet.
.
No abstract available
Comment in
-
Challenging the management of drug-resistant tuberculosis - Authors' reply.Lancet. 2020 Mar 7;395(10226):783-784. doi: 10.1016/S0140-6736(20)30055-6. Lancet. 2020. PMID: 32145791 No abstract available.
Comment on
-
Management of drug-resistant tuberculosis.Lancet. 2019 Sep 14;394(10202):953-966. doi: 10.1016/S0140-6736(19)31882-3. Lancet. 2019. PMID: 31526739 Free PMC article. Review.
Similar articles
-
Challenging the management of drug-resistant tuberculosis.Lancet. 2020 Mar 7;395(10226):783. doi: 10.1016/S0140-6736(20)30049-0. Lancet. 2020. PMID: 32145792 No abstract available.
-
Multidrug resistant tuberculosis with multiple organ involvement.Tuberk Toraks. 2012;60(3):261-4. Tuberk Toraks. 2012. PMID: 23030753
-
Bedaquiline: a novel antitubercular drug for multidrug-resistant tuberculosis.J Postgrad Med. 2014 Jul-Sep;60(3):300-2. doi: 10.4103/0022-3859.138772. J Postgrad Med. 2014. PMID: 25121373
-
Management of Multidrug-Resistant Tuberculosis.Semin Respir Crit Care Med. 2018 Jun;39(3):310-324. doi: 10.1055/s-0038-1661383. Epub 2018 Aug 2. Semin Respir Crit Care Med. 2018. PMID: 30071546 Review.
-
Host-targeted therapy for tuberculosis: Time to revisit the concept.Indian J Med Res. 2018 Mar;147(3):233-238. doi: 10.4103/ijmr.IJMR_652_17. Indian J Med Res. 2018. PMID: 29923511 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
